The Great Aspirin Reversal: A Decade of Change
New data from Epic Research reveals a dramatic shift in the use of low-dose, or "baby," aspirin for the primary prevention of cardiovascular disease. Between 2018 and 2025, the rate of use has more than halved, dropping from 7.2% to 3.2%.
"The decline is consistent across age groups, though 5.7% of adults aged 80 and older continue to use it."
A Timeline of Changing Advice
This sharp decline in aspirin use is a direct result of major shifts in clinical guidelines over the past decade. The medical establishment has moved from a position of recommending aspirin for many, to one of caution for most.
- 2016: The U.S. Preventive Services Task Force (USPSTF) recommended aspirin for certain adults aged 50-59 who had a high risk of cardiovascular disease and a low risk of bleeding.
- 2019: The American College of Cardiology and American Heart Association changed course, recommending against aspirin for primary prevention, except for select high-risk adults aged 40-70.
- 2022: The USPSTF ultimately recommended that adults aged 60 and older not start taking aspirin for primary prevention.
Why the Medical Consensus Changed
The reversal in guidelines is rooted in a critical reassessment of the evidence.
The Risk-Benefit Calculus
According to cardiologist Jim Liu, studies simply did not consistently show a significant benefit from aspirin for primary prevention. This is because the potential for harm is substantial.
"Aspirin carries risks of bleeding and gastrointestinal side effects."
Better Tools, Safer Options
Cardiologist Corey Bradley points to a more fundamental reason for the change: we have gotten better at managing heart disease without aspirin. Improvements in aggressively treating high cholesterol and high blood pressure have proven to be more effective and safer than aspirin for preventing a first heart attack or stroke.
Who Should Still Take Baby Aspirin?
Despite the broad shift against primary prevention, aspirin remains a critical therapy for specific patient groups.
Clear Recommendation for Secondary Prevention
Daily baby aspirin is strongly recommended for anyone who has already experienced a cardiovascular event, such as a heart attack, stroke, or had a stent placed. Cardiologist Kevin Shah confirms this standard of care.
Individualized Decisions for Specific Cases
The decision is less black-and-white for others. The current guidance emphasizes a personalized approach based on a detailed risk assessment.
Cardiologist Aeshita Dwivedi explains that she personally still recommends aspirin for some of her patients—specifically those with moderate to severe atherosclerosis. She stresses that these are nuanced, individual decisions weighing a patient's exact cardiovascular risk against their bleeding risk.